Related references
Note: Only part of the references are listed.A systematic review and meta-analysis of early goal-directed therapy for septic shock: the ARISE, ProCESS and ProMISe Investigators
D. C. Angus et al.
INTENSIVE CARE MEDICINE (2015)
Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial
Didier M. Payen et al.
INTENSIVE CARE MEDICINE (2015)
Postoperative Polymyxin B Hemoperfusion and Mortality in Patients With Abdominal Septic Shock: A Propensity-Matched Analysis
Masao Iwagami et al.
CRITICAL CARE MEDICINE (2014)
The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial
David J. Klein et al.
TRIALS (2014)
Blood Purification and Mortality in Sepsis: A Meta-Analysis of Randomized Trials
Feihu Zhou et al.
CRITICAL CARE MEDICINE (2013)
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012
R. Phillip Dellinger et al.
CRITICAL CARE MEDICINE (2013)
The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study
Jean-Pierre Quenot et al.
CRITICAL CARE (2013)
Management of severe sepsis in patients admitted to Asian intensive care units: prospective cohort study
Jason Phua et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation
Alan E. Jones et al.
CRITICAL CARE MEDICINE (2009)
Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock The EUPHAS Randomized Controlled Trial
Dinna N. Cruz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors
Vincenzo Cantaluppi et al.
INTENSIVE CARE MEDICINE (2008)
Effects of PMX-DHP treatment for patients with directly induced acute respiratory distress syndrome
Kenji Tsushima et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2007)
Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review
Dinna N. Cruz et al.
CRITICAL CARE (2007)
Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation
H Kushi et al.
CRITICAL CARE (2005)
Diagnostic and prognostic implications of endotoxemia in critical illness: Results of the MEDIC study
JC Marshall et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Extracorporeal endotoxin removal for the treatment of sepsis: Endotoxin adsorption cartridge (Toraymyxin)
H Shoji
THERAPEUTIC APHERESIS AND DIALYSIS (2003)
Endotoxin as a drug target
SM Opal et al.
CRITICAL CARE MEDICINE (2003)
Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence
JC Marshall et al.
CRITICAL CARE (2002)
Continuous Hemodiafiltration with polymyxin-B immobilized fiber is effective in patients with sepsis syndrome and acute renal failure
H Suzuki et al.
THERAPEUTIC APHERESIS (2002)
Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock
K Uriu et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Serial evaluation of the SOFA score to predict outcome in critically ill patients
FL Ferreira et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis
H Nemoto et al.
BLOOD PURIFICATION (2001)
Share Paper
